IL6 and Duchenne muscular dystrophy: In light of this, EVs derived from BMSCs were designed to express IL6 signal transducer decoy receptors to selectively inhibit the IL6 transsignaling pathway and have no effects on classical signaling, thereby provided a potential for the treatment of DMD [194].